CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing adoption of prefilled syringes
4.1.2. Growth in fill-finish outsourcing
4.1.3. Development of the biopharmaceutical industry
4.1.4. Technological advancement in fill-finish products
4.2. Market Restraints & Challenges
4.2.1. Challenges associated with manufacturing prefilled syringes
4.2.2. High costs associated with isolators/Rabs
4.3. Market Opportunities
4.3.1. Unexplored therapeutic applications
4.3.2. The growth of biomanufacturing in emerging markets
CHAPTER 5. GLOBAL FILL FINISH MANUFACTURING MARKET – BY
PRODUCT
5.1 Introduction
5.2 Consumables
5.2.1.Prefilled syringes
5.2.1.1. Glass prefilled syringes
5.2.1.2. Plastic prefilled syringes
5.2.2 Cartridges
5.3.3.vials
5.3.4 other consumables
5.3. Instruments
CHAPTER 6. GLOBAL FILL FINISH MANUFACTURING MARKET – BY END
USER
6.1. Introduction
6.2. Biopharmaceutical companies
6.3. Contract manufacturing organisations
6.4. Other end users
CHAPTER 7. GLOBAL FILL FINISH MANUFACTURING MARKET - BY
GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.7. Switzerland
7.4.8. Poland
7.4.9. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL FILL FINISH MANUFACTURING MARKET - COMPANY
PROFILES
8.1. Stevanato Group.
8.2. Becton, Dickinson and Company
8.3. Bausch + Ströbel.
8.4. Nipro Medical Corporation.
8.5. West Pharmaceutical Services, Inc.
8.6. Groninger & Co. gmbh
8.7. Schott AG.
8.8. Kia Optima.
8.9. The Indian Medical Association.
8.10. Robert Bosch GmbH.
8.11. Gerresheimer AG.
8.12. Dara Pharmaceutical Packaging.
8.13. Abbott Laboratories
8.14. Ranbaxy Laboratories Ltd.
8.15. Sun Pharmaceutical Industries Ltd
CHAPTER 9. GLOBAL FILL FINISH MANUFACTURING MARKET -
COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
